Cambridge Investment Research Advisors, Inc. quarter change: Foreign ADRs, Unchanged
In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), from the quarter ended 2026-03-31 to 2026-06-30, Cambridge Investment Research Advisors, Inc. opened 0 positions, added to 0, reduced 0, sold out of 2 and left 0 unchanged. The largest increase in value was ASCENDIS PHARMA A/S SPONSORED (-$302); the largest decrease was NOVA MINERALS LTD SPONSORED (-$538).
Two Form 13F-HR filings compared (SEC CIK 1419186): 2026-03-31 (filed 2026-04-30) and 2026-06-30 (filed 2026-07-27). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
No position of this class changed this way between the two filings.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| VANGUARD MARKETING CORPORATION | United States | $0.039B | 1 |
| Silversmith Partners I GP, LLC | United States | $0.039B | 1 |
| Index Venture Associates III Ltd | Jersey | $0.039B | 1 |
| Diana Davis Spencer Foundation | United States | $0.039B | 2 |
| BLKBRD Asset Management, LP | United States | $0.038B | 21 |
| TCG Capital Management, LP | United States | $0.039B | 1 |
| ECLIPSE OPERATIONS, LLC | United States | $0.040B | 1 |
| 8VC GP I, LLC | United States | $0.040B | 1 |
| INDUS CAPITAL PARTNERS, LLC | United States | $0.040B | 2 |
| CROSSPOINT FINANCIAL, LLC | United States | $0.040B | 35 |